507 related articles for article (PubMed ID: 25042981)
21. Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children.
Thyagarajan A; Jones SM; Calatroni A; Pons L; Kulis M; Woo CS; Kamalakannan M; Vickery BP; Scurlock AM; Wesley Burks A; Shreffler WG
Clin Exp Allergy; 2012 Aug; 42(8):1197-205. PubMed ID: 22805467
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of oral immunotherapy.
Barshow SM; Kulis MD; Burks AW; Kim EH
Clin Exp Allergy; 2021 Apr; 51(4):527-535. PubMed ID: 33417257
[TBL] [Abstract][Full Text] [Related]
23. Oral Immunotherapy and Basophil and Mast Cell Reactivity in Food Allergy.
Paranjape A; Tsai M; Mukai K; Hoh RA; Joshi SA; Chinthrajah RS; Nadeau KC; Boyd SD; Galli SJ
Front Immunol; 2020; 11():602660. PubMed ID: 33381123
[TBL] [Abstract][Full Text] [Related]
24. IgE promotes type 2 innate lymphoid cells in murine food allergy.
Burton OT; Medina Tamayo J; Stranks AJ; Miller S; Koleoglou KJ; Weinberg EO; Oettgen HC
Clin Exp Allergy; 2018 Mar; 48(3):288-296. PubMed ID: 29247574
[TBL] [Abstract][Full Text] [Related]
25. Differential response in allergen-specific IgE, IgGs, and IgA levels for predicting outcome of oral immunotherapy.
Sugimoto M; Kamemura N; Nagao M; Irahara M; Kagami S; Fujisawa T; Kido H
Pediatr Allergy Immunol; 2016 May; 27(3):276-82. PubMed ID: 26764899
[TBL] [Abstract][Full Text] [Related]
26. Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens.
Vickery BP; Lin J; Kulis M; Fu Z; Steele PH; Jones SM; Scurlock AM; Gimenez G; Bardina L; Sampson HA; Burks AW
J Allergy Clin Immunol; 2013 Jan; 131(1):128-34.e1-3. PubMed ID: 23199605
[TBL] [Abstract][Full Text] [Related]
27. Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan.
Nagakura KI; Yanagida N; Sato S; Nishino M; Asaumi T; Ogura K; Ebisawa M
Pediatr Allergy Immunol; 2018 Aug; 29(5):512-518. PubMed ID: 29603410
[TBL] [Abstract][Full Text] [Related]
28. An unexpected protective role of low-affinity allergen-specific IgG through the inhibitory receptor FcγRIIb.
Zha L; Leoratti FMS; He L; Mohsen MO; Cragg M; Storni F; Vogel M; Bachmann MF
J Allergy Clin Immunol; 2018 Nov; 142(5):1529-1536.e6. PubMed ID: 29391255
[TBL] [Abstract][Full Text] [Related]
29. Blockade of peanut allergy with a novel Ara h 2-Fcγ fusion protein in mice.
Liu Y; Sun Y; Chang LJ; Li N; Li H; Yu Y; Bryce PJ; Grammer LC; Schleimer RP; Zhu D
J Allergy Clin Immunol; 2013 Jan; 131(1):213-21.e1-5. PubMed ID: 23199607
[TBL] [Abstract][Full Text] [Related]
30. IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells.
Galand C; Leyva-Castillo JM; Yoon J; Han A; Lee MS; McKenzie ANJ; Stassen M; Oyoshi MK; Finkelman FD; Geha RS
J Allergy Clin Immunol; 2016 Nov; 138(5):1356-1366. PubMed ID: 27372570
[TBL] [Abstract][Full Text] [Related]
31. Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.
Scurlock AM
Clin Rev Allergy Immunol; 2018 Oct; 55(2):139-152. PubMed ID: 29656306
[TBL] [Abstract][Full Text] [Related]
32. Patterns of immunoglobulin G responses to egg and peanut allergens are distinct: ovalbumin-specific immunoglobulin responses are ubiquitous, but peanut-specific immunoglobulin responses are up-regulated in peanut allergy.
Tay SS; Clark AT; Deighton J; King Y; Ewan PW
Clin Exp Allergy; 2007 Oct; 37(10):1512-8. PubMed ID: 17883730
[TBL] [Abstract][Full Text] [Related]
33. High- and low-dose oral immunotherapy similarly suppress pro-allergic cytokines and basophil activation in young children.
Kulis M; Yue X; Guo R; Zhang H; Orgel K; Ye P; Li Q; Liu Y; Kim E; Burks AW; Vickery BP
Clin Exp Allergy; 2019 Feb; 49(2):180-189. PubMed ID: 30126028
[TBL] [Abstract][Full Text] [Related]
34. IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitization.
Uermösi C; Zabel F; Manolova V; Bauer M; Beerli RR; Senti G; Kündig TM; Saudan P; Bachmann MF
Allergy; 2014 Mar; 69(3):338-47. PubMed ID: 24354793
[TBL] [Abstract][Full Text] [Related]
35. Epicutaneous immunotherapy induces gastrointestinal LAP
Tordesillas L; Mondoulet L; Blazquez AB; Benhamou PH; Sampson HA; Berin MC
J Allergy Clin Immunol; 2017 Jan; 139(1):189-201.e4. PubMed ID: 27417020
[TBL] [Abstract][Full Text] [Related]
36. High-resolution epitope mapping by AllerScan reveals relationships between IgE and IgG repertoires during peanut oral immunotherapy.
Chen G; Shrock EL; Li MZ; Spergel JM; Nadeau KC; Pongracic JA; Umetsu DT; Rachid R; MacGinnitie AJ; Phipatanakul W; Schneider L; Oettgen HC; Elledge SJ
Cell Rep Med; 2021 Oct; 2(10):100410. PubMed ID: 34755130
[TBL] [Abstract][Full Text] [Related]
37. The safety and efficacy of sublingual and oral immunotherapy for milk allergy.
Keet CA; Frischmeyer-Guerrerio PA; Thyagarajan A; Schroeder JT; Hamilton RG; Boden S; Steele P; Driggers S; Burks AW; Wood RA
J Allergy Clin Immunol; 2012 Feb; 129(2):448-55, 455.e1-5. PubMed ID: 22130425
[TBL] [Abstract][Full Text] [Related]
38. Oral immunotherapy induces local protective mechanisms in the gastrointestinal mucosa.
Leonard SA; Martos G; Wang W; Nowak-Węgrzyn A; Berin MC
J Allergy Clin Immunol; 2012 Jun; 129(6):1579-1587.e1. PubMed ID: 22554705
[TBL] [Abstract][Full Text] [Related]
39. Development and transfer of immediate cutaneous hypersensitivity in mice exposed to aerosolized antigen.
Saloga J; Renz H; Lack G; Bradley KL; Greenstein JL; Larsen G; Gelfand EW
J Clin Invest; 1993 Jan; 91(1):133-40. PubMed ID: 8423213
[TBL] [Abstract][Full Text] [Related]
40. Low-Dose Oral Immunotherapy Using Low-Egg-Allergen Cookies for Severe Egg-Allergic Children Reduces Allergy Severity and Affects Allergen-Specific Antibodies in Serum.
Maeta A; Matsushima M; Muraki N; Asano M; Takaoka Y; Kameda M; Takahashi K
Int Arch Allergy Immunol; 2018; 175(1-2):70-76. PubMed ID: 29332094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
